Solid Biosciences Inc.SLDBNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank20
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P20
Within normal range
Average
-170.55%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%-
20230.00%+100.0%
2022-1196.76%-135.2%
2021-508.74%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-